Trial intelligence / Profile preview

Systemic Steroids after FESS for CRSwNP

NCT04915456Phase 4Completed

Sponsor
Friedrich-Alexander University Erlangen-Nuremberg
Start
Jan 2005
Primary completion
Apr 2020
Modality
Orthosteric Ligands
01

Overview

Phase 4, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Systemic steroid (Prednisolone) with Placebo (2 arms). Primary endpoint: Nasal Polyp Score at 24 months. Started Jan 2005; status: completed.

02

Drugs

prednisolone
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on NCT04915456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04915456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call